Literature DB >> 28775452

CHRONIC HEPATITIS IN PATIENTS OF CHRONIC RENAL FAILURE.

A S Narula1, N R Chaudhury1, S K Thakur2, S D Karloopia3, V S Kolhe4, S S Chauhan5.   

Abstract

Entities:  

Year:  2017        PMID： 28775452      PMCID： PMC5531391          DOI： 10.1016/S0377-1237(17)30508-7

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  12 in total

Review 1.  Classification of chronic viral hepatitis: a need for reassessment.

Authors:  P J Scheuer
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

2.  A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.

Authors:  R P Perrillo; E R Schiff; G L Davis; H C Bodenheimer; K Lindsay; J Payne; J L Dienstag; C O'Brien; C Tamburro; I M Jacobson; R Sampliner; D Feit; J Lefkowitch; M Kuhns; C Meschievitz; B Sanghvi; J Albrecht; A Gibas
Journal:  N Engl J Med       Date:  1990-08-02       Impact factor: 91.245

3.  Renal transplantation and hepatitis B.

Authors:  J L Dienstag
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

4.  Hepatitis B infection in a dialysis unit in South India.

Authors:  P Thomas; M G Kirubakaran; C K Jacob; N S Srinivasa; S Hariharan; T J John; J C Shastry
Journal:  J Assoc Physicians India       Date:  1987-04

5.  Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients.

Authors:  J Crosnier; P Jungers; A M Couroucé; A Laplanche; E Benhamou; F Degos; B Lacour; P Prunet; Y Cerisier; P Guesry
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

Review 6.  The clinical course and chronic sequelae of hepatitis B virus infection.

Authors:  R P Perrillo; R D Aach
Journal:  Semin Liver Dis       Date:  1981-02       Impact factor: 6.115

7.  Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients.

Authors:  M Bruguera; J L Rodicio; J M Alcazar; A Oliver; G Del Rio; R Esteban-Mur
Journal:  Vaccine       Date:  1990-03       Impact factor: 3.641

8.  Chronic non-A, non-B hepatitis complicated by end-stage renal failure treated with recombinant interferon alpha.

Authors:  M E Ellis; O Alfurayh; M A Halim; J O Sieck; M A Ali; S S Bernvil; H Ali; Y Barri; A Ayub; M al-Fadda
Journal:  J Hepatol       Date:  1993-06       Impact factor: 25.083

9.  Long-term results and complications in renal transplant recipients. Observations in the second decade.

Authors:  K V Rao; R C Andersen
Journal:  Transplantation       Date:  1988-01       Impact factor: 4.939

10.  Poor response to a recombinant hepatitis B vaccine in dialysis patients.

Authors:  S J Fleming; D M Moran; W G Cooksley; J L Faoagali
Journal:  J Infect       Date:  1991-05       Impact factor: 6.072
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.